Trials / Active Not Recruiting
Active Not RecruitingNCT04917757
Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas
Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas - Substudy of the ENSAT (European Network for the Study of Adrenal Tumor) Registry
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,656 (actual)
- Sponsor
- Wuerzburg University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of the study is to assess mortality and cardiovascular events potentially linked to cortisol excess in patients with adrenal incidentalomas stratified by cortisol values following the 1-mg overnight dexamethasone test.
Detailed description
The NAPACA Outcome Study is part of the ENSAT Registry (https://registry.ensat.org/)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 1mg Dexamethasone test | For each patient a 1mg dexamethasone test has been performed. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2019-08-31
- Completion
- 2025-12-31
- First posted
- 2021-06-08
- Last updated
- 2025-09-05
- Results posted
- 2024-10-08
Locations
2 sites across 2 countries: Germany, Italy
Source: ClinicalTrials.gov record NCT04917757. Inclusion in this directory is not an endorsement.